97. 潰瘍性大腸炎 Ulcerative colitis Clinical trials / Disease details


臨床試験数 : 2,527 薬物数 : 1,468 - (DrugBank : 259) / 標的遺伝子数 : 143 - 標的パスウェイ数 : 201

  
2 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT00616434
(ClinicalTrials.gov)
May 20085/2/2008A Phase 2 Study of Interferon Beta-1a (Avonex®) in Ulcerative ColitisA Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of Avonex® in Subjects With Moderate to Severe Ulcerative ColitisActive Ulcerative ColitisDrug: BG9418 (Interferon beta-1a);Drug: PlaceboBiogenNULLCompleted18 Years65 YearsAll123Phase 2United States;Canada;Czech Republic;Hungary;Poland;Russian Federation;Slovakia
2NCT00303381
(ClinicalTrials.gov)
December 200114/3/2006Safety and Efficacy of Interferon-Beta-1a (Rebif®) for Treating Subjects With Acute Symptoms of Ulcerative ColitisA Multicentre, Randomised, Double-blind, Placebo-controlled, Dose-finding Phase II Study of Subcutaneously Administered IFN-beta-1a in the Treatment of Patients With Moderately Active Ulcerative ColitisUlcerative ColitisDrug: Interferon-beta-1a, 44 microgram;Drug: Placebo;Drug: Interferon-beta-1a, 66 microgramEMD SeronoMerck Serono International SACompleted18 YearsN/ABoth194Phase 2Germany;Israel;Netherlands;Singapore;Sweden;Switzerland;United Kingdom;Spain